Las enfermedades cardiovasculares constituyen la principal causa de mortalidad en mujeres a nivel mundial. Aunque España presenta una de las tasas de fallecimiento más bajas de Europa, estas patologías son, también en nuestro país, la principal causa de defunción entre las mujeres.
Por otro lado, existen diferencias significativas en la forma en que se trata a las mujeres con enfermedades cardiovasculares, que podrían impactar en su pronóstico. Pero ¿se observan también esas diferencias en el campo de las arritmias? Cristina Lozano profundiza en esta cuestión en CardioPODCAST con Concepción Alonso, Victoria Cañadas y Sofía Calero.
Participantes:
Cristina Lozano GraneroHospital Universitario Ramón y Cajal, Madrid
Concepción Alonso MartínHospital de la Santa Creu i Sant Pau, Barcelona
Victoria Cañadas GodoyHospital Clínico San Carlos, Madrid
Sofía Calero NúñezHospital General Universitario de Albacete
- Proyecto institucional Mujer y Corazón
- How to use digital devices to detect and manage arrhythmias: an EHRA practical guide. EP Eur. 1 de junio de 2022;24(6):979-1005.
- Symptom burden guiding invasive electrophysiological study in paroxysmal supraventricular tachycardia: The believe SVT registry. Am Heart J. marzo de 2024;269:15-24.
- Differences in Clinical and Functional Outcomes of Atrial Fibrillation in Women and Men: Two-Year Results From the ORBIT-AF Registry. JAMA Cardiol. 1 de junio de 2016;1(3):282-91.
- Sex-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Observational Research Programme Pilot survey on Atrial Fibrillation. Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol. enero de 2015;17(1):24-31.
- Evaluation of sex differences in the receipt of concomitant atrial fibrillation procedures during nonmitral cardiac surgery. J Thorac Cardiovasc Surg. 29 de abril de 2024;S0022-5223(24)00309-X.
- Sex-based differences and risk of recurrence in patients with atrial fibrillation undergoing pulmonary vein isolation. Int J Cardiol. 12 de mayo de 2024;409:132161.
- Rates of pulmonary vein reconnection at repeat ablation for recurrent atrial fibrillation and its impact on outcomes among females and males. Pacing Clin Electrophysiol PACE. 11 de abril de 2024
- Stroke risk in women with atrial fibrillation. Eur Heart J. 7 de enero de 2024;45(2):104-13.
- Sex Differences in Device Therapies for Ventricular Arrhythmias or Death in the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) Trial. J Cardiovasc Electrophysiol. agosto de 2015;26(8):862-71.
- Sex differences in the use of implantable cardioverter-defibrillators for primary and secondary prevention of sudden cardiac death. JAMA. 3 de octubre de 2007;298(13):1517-24.
- Gender and outcomes after primary prevention implantable cardioverter-defibrillator implantation: Findings from the National Cardiovascular Data Registry (NCDR). Am Heart J. agosto de 2015;170(2):330-8.
- Cardiac resynchronization therapy is more effective in women than in men: the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy) trial. J Am Coll Cardiol. 15 de febrero de 2011;57(7):813-20.
- Temporal and geographical trends in women operators of electrophysiology procedures in the United States. Heart Rhythm. 1 de mayo de 2022;19(5):807-11.
- Occupational radiation exposure of electrophysiology staff with reproductive potential and during pregnancy: an EHRA survey. Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol. 2 de agosto de 2023;25(9):euad216.
- Radiation protection for healthcare professionals working in catheterisation laboratories during pregnancy: a statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) in collaboration with the European Heart Rhythm Association (EHRA), the European Association of Cardiovascular Imaging (EACVI), the ESC Regulatory Affairs Committee and Women as One. EuroIntervention J Eur Collab Work Group Interv Cardiol Eur Soc Cardiol. 15 de mayo de 2023;19(1):53-62.
